BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28448870)

  • 1. Knockdown of MSP58 inhibits the proliferation and metastasis in human renal cell carcinoma cells.
    Zhai X; Wu Y; Zhang D; Chong T; Zhao J
    Biomed Pharmacother; 2017 Jul; 91():54-59. PubMed ID: 28448870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC01510 suppresses cell proliferation and invasion by inhibiting Wnt/β-catenin signaling in renal cell carcinoma.
    Ma B; Zhang J; Zhou W; Chu C; Zhao C; Zhang Z; Huang T
    Biochem Biophys Res Commun; 2018 Oct; 505(1):7-12. PubMed ID: 30224058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi-mediated inhibition of MSP58 decreases tumour growth, migration and invasion in a human glioma cell line.
    Lin W; Zhang J; Zhang J; Liu X; Fei Z; Li X; Davidovic L; Tang Z; Shen L; Deng Y; Yang A; Han H; Zhang X; Yao L
    J Cell Mol Med; 2009; 13(11-12):4608-22. PubMed ID: 18798870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
    Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
    Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
    Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
    Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Expression of 58-kDa Microspherule Protein (MSP58) in Human Gastric Cancer Promotes Cell Proliferation and Correlates with Poor Patient Survival.
    Cui J; Xi H; Cai A; Ma L; Bian S; Zhang K; Wei B; Chen L
    Clin Lab; 2016; 62(6):993-1001. PubMed ID: 27468560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM59 is a key regulator of growth and migration inrenal cell carcinoma.
    Hu SH; Zhao MJ; Wang WX; Xu CW; Wang GD
    Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):68-74. PubMed ID: 28719348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of PLOD3 suppresses the malignant progression of renal cell carcinoma via reducing TWIST1 expression.
    Xie D; Li J; Wei S; Qi P; Ji H; Su J; Du N; Zhang X
    Mol Cell Probes; 2020 Oct; 53():101608. PubMed ID: 32585183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
    Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
    PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of FSTL3 abates the proliferation and metastasis of renal cell carcinoma via the GSK-3β/β-catenin signaling pathway.
    Sun F; Sun P; Yang X; Hu L; Gao J; Tian T
    Aging (Albany NY); 2021 Sep; 13(18):22528-22543. PubMed ID: 34555811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Collagen Triple Helix Repeat Containing-1 Inhibits the Proliferation and Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma Cells.
    Jin XF; Li H; Zong S; Li HY
    Oncol Res; 2016 Oct; 24(6):477-485. PubMed ID: 28281968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
    Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
    J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
    Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
    Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
    J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.
    Ping JG; Wang F; Pu JX; Hou PF; Chen YS; Bai J; Zheng JN
    Tumour Biol; 2016 Sep; 37(9):12823-12831. PubMed ID: 27449035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
    Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
    Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway.
    Wang H; Qu Y; Dai B; Zhu Y; Shi G; Zhu Y; Shen Y; Zhang H; Ye D
    PLoS One; 2017; 12(8):e0180862. PubMed ID: 28846693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway.
    Shi H; Chen S; Jin H; Xu C; Dong G; Zhao Q; Wang W; Zhang H; Lin W; Zhang J; Davidovic L; Yao L; Fan D
    Cancer Sci; 2009 Sep; 100(9):1585-90. PubMed ID: 19549253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.